Scientists investigate why 1 in 5 migraine sufferers Don't respond to common drugs
NCT ID NCT07177885
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study looks at why some people with migraine don't get relief from triptan medications. Researchers will measure levels of tryptophan, a natural substance that affects pain and inflammation, in 144 adults who either respond well or poorly to triptans. The goal is to understand the biological differences between these groups to improve future treatments. Participants may not benefit directly from this study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.